Cargando…
Biometrical issues in the analysis of adverse events within the benefit assessment of drugs
The analysis of adverse events plays an important role in the benefit assessment of drugs. Consequently, results on adverse events are an integral part of reimbursement dossiers submitted by pharmaceutical companies to health policy decision‐makers. Methods applied in the analysis of adverse events...
Autores principales: | Bender, Ralf, Beckmann, Lars, Lange, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069571/ https://www.ncbi.nlm.nih.gov/pubmed/26928768 http://dx.doi.org/10.1002/pst.1740 |
Ejemplares similares
-
Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs
por: Skipka, Guido, et al.
Publicado: (2016) -
Emerging issues in peripheral nerve repair☆
por: Geuna, Stefano, et al.
Publicado: (2012) -
On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018) -
Understanding face identification through within-person variability in appearance: Introduction to a virtual special issue
por: Bindemann, Markus, et al.
Publicado: (2020) -
JBMRPlus: Special Issue on Rare Bone Diseases 2019
por: Shore, Eileen M., et al.
Publicado: (2019)